Medtronic (MDT) Payables (2014 - 2026)

Medtronic has disclosed Payables across 13 years of filings, most recently posting $2.7 billion for Q3 2026.

• In Q3 2026, Payables rose 5.48% year-over-year to $2.7 billion; the TTM figure through Jul 2026 stood at $2.7 billion (up 5.48% YoY), while the FY2026 annual figure was $2.6 billion, up 7.96% from the prior year.
• Payables came in at $2.7 billion for Q3 2026 at Medtronic, up from $2.6 billion in the prior quarter.
• In the past five years, Payables ranged from a high of $2.7 billion in Q3 2026 to a low of $2.0 billion in Q1 2022.
• Average Payables over 5 years is $2.4 billion, with a median of $2.3 billion recorded in 2024.
• Year-over-year, Payables gained 16.96% in 2023 and decreased 9.82% in 2024.
• Over 5 years, Payables stood at $2.2 billion in 2022, then retreated by 1.09% to $2.2 billion in 2023, then grew by 9.29% to $2.4 billion in 2024, then climbed by 8.63% to $2.6 billion in 2025, then gained by 4.42% to $2.7 billion in 2026.
• Per Business Quant data, the three most recent Payables figures were $2.7 billion in Q3 2026, $2.6 billion in Q2 2026, and $2.6 billion in Q1 2026.